June 15, 2020
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The US Food and Drug Administration (FDA) revoked its decision from March […]
June 15, 2020
The US Food and Drug Administration (FDA) has approved the first dispersible tablet formulation of dolutegravir (Tivicay PD, ViiV Healthcare) to treat HIV-1 infection in children […]
June 15, 2020
For patients with high-risk chronic lymphocytic leukemia (CLL), first-line therapy with a triple combination of targeted agents showed encouraging response rates in the phase 2 CLL2-GIVe […]
June 13, 2020
Semglee, a long-acting human insulin analogue, has been approved for glycemic control in adults and children with type 1 diabetes and adults with type 2 diabetes, the […]
June 12, 2020
Medtronic’s next-generation automated insulin delivery system, the MiniMed 780G, has received a CE mark for the treatment of type 1 diabetes in people aged 7 to […]
June 5, 2020
The US Food and Drug Administration (FDA) is notifying healthcare providers about the temporary absence of the words “paralyzing agent” on the vial caps of two […]
June 4, 2020
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. The Lancet announced today that it has retracted a highly cited study that […]
June 4, 2020
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Convalescent plasma was found to be safe and effective in 14 of […]
June 1, 2020
The US Food and Drug Administration has approved ticagrelor (Brilinta/Brilique, AstraZeneca) for use with aspirin to cut the risk for a first myocardial infarction (MI) or […]